Case report links tirzepatide dose escalation to lactic acidosis and euglycemic DKA
A 64-year-old woman on metformin and tirzepatide presented in shock after two weeks of markedly reduced oral intake following a dose increase.
MH
By Maren Holt · Senior Reporter, GLP-1
Jun 30 20:00 ETSource: Endocrinology, diabetes & metabolism case reports
The wire
- 01Clinicians describe concurrent metformin-associated lactic acidosis and euglycemic diabetic ketoacidosis in a woman with type 2 diabetes who ate little for two weeks after tirzepatide escalation; she required intubation, vasopressors and continuous renal replacement therapy.
- 02The authors attribute the picture to starvation ketosis plus dehydration and acute kidney injury impairing metformin clearance, a combination relevant when incretin therapy continues through prolonged poor intake.
- 03She improved rapidly after metformin and tirzepatide were stopped; this is a single case report and cannot establish incidence or causation.
From the source
Read at pubmed.ncbi.nlm.nih.govConcurrent metformin-associated lactic acidosis and euglycemic diabetic ketoacidosis from tirzepatide starvation ketosis
Endocrinology, diabetes & metabolism case reports · 2026 Jul 1 · Epitropoulos F, Brijawi O, Ghuman K et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42789768/
